Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Neuroendocrine Tumors × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

repotrectinib 1 pralsetinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 entrectinib 1 cabozantinib 1 X-Rays 1 Specimen Handling 1 Phantoms, Imaging 1 Octreotide 1 Magnetic Resonance Spectroscopy 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡